Ana P. Vargas-Macías
Manuela Gómez-Gaviria
Héctor M. Mora-Montes- División de Ciencias Naturales y Exactas, Departamento de Biología, Universidad de Guanajuato, Guanajuato, Mexico
Sporotrichosis is a worldwide distributed subcutaneous mycosis that affects mammals, including human beings. The infection is caused by members of the Sporothrix pathogenic clade, which includes Sporothrix schenckii, Sporothrix brasiliensis, and Sporothrix globosa. The fungus can be acquired through traumatic inoculation of conidia growing in vegetal debris or by zoonotic transmission from sick animals. Although is not considered a life-threatening disease, it is an emergent health problem that affects mostly immunocompromised patients. The sporotrichosis causative agents differ in their virulence, host range, and sensitivity to antifungal drugs; therefore, it is relevant to understand the molecular bases of their pathogenesis, interaction with immune effectors, and mechanisms to acquired resistance to antifungal compounds. Murine models are considered the gold standard to address these questions; however, some alternative hosts offer numerous advantages over mammalian models, such as invertebrates like Galleria mellonella and Tenebrio molitor, or ex vivo models, which are useful tools to approach questions beyond virulence, without the ethical or budgetary features associated with the use of animal models. In this review, we analyze the different models currently used to study the host-Sporothrix interaction.
Introduction
Sporotrichosis is a benign subcutaneous mycosis that shows different clinical manifestations, with lesions usually restricted to the skin, subcutaneous tissue, or adjacent lymphatic vessels. It can affect both humans and other mammals. However, in immunocompromised patients, the disease can be a life-threatening systemic or disseminated infection (Barros et al., 2011; López-Romero et al., 2011). The etiological agents are members of the Sporothrix clinical clade, which includes Sporothrix schenckii, Sporothrix brasiliensis, and Sporothrix globosa (de Beer et al., 2016), the most frequently isolated species from both clinical and veterinary cases (Lopes-Bezerra et al., 2018a). These species have different distribution patterns, being S. brasiliensis mainly restricted to Brasil and Argentina, and S. schenckii and S. globosa with a worldwide distribution, but found preferentially in America and Asia, respectively (Chakrabarti et al., 2015; Mora-Montes et al., 2015; Lopes-Bezerra et al., 2018a; Etchecopaz et al., 2020). Sporotrichosis is acquired through traumatic inoculation with vegetal material contaminated with the mycelial morphology, thus being considered as a sapronosis, or through zoonotic transmission by domestic animals, most frequently by cats that inoculate the yeast morphology directly into the host (Mora-Montes et al., 2015; Lopes-Bezerra et al., 2018a). Feline sporotrichosis is mainly associated with S. brasiliensis (Rodrigues et al., 2016).
The study of fungal virulence is critical to understanding the outcome of the host-pathogen interactions, the different disease presentations, the molecular bases of tissue-damaging, and those that allow the hosts' cells to defend themselves, and the ability of the fungal cells to divert or respond against the host's immunity. Therefore, virulence is an essential aspect to take into account during the development of new alternatives for fungal infections treatment and prophylaxis. Traditionally, virulence is analyzed in vivo, using laboratory animals that mimic the fungal infective cycle and the host immune response; and mammals, in particular mice, are currently the gold standard to experimentally evaluate sporotrichosis and Sporothrix spp. virulence. However, some other models have been proposed, such as ex vivo experimental models that use endothelial and immune cells, and non-conventional invertebrate hosts, such as Galleria mellonella, Tenebrio molitor, and Acanthamoeba castellanii. In this review, some of the main models to study Sporothrix spp. virulence will be discussed, underlining the applications of each model (see Figure 1).
Figure 1. Particularities and similarities of vertebrates, invertebrate, and ex vivo models to experimentally study sporotrichosis. The Sporothrix-host interaction has been assessed in vertebrate models such as mice, rats, guinea pigs, and cats; invertebrates, including Galleria mellonella, Tenebrio molitor, and Acanthamoeba castellanii; and ex vivo models such as endothelial cells, macrophages, human peripheral blood mononuclear cells, mast cells, dendritic cells, cell lines, and feline claw fragments. These models have particularities that differentiate them from each other, but they also share applicabilities in the study of host-Sporothrix spp. interplay.
Mammalian Models to Study Sporotrichosis
The study of fungal pathogenesis is traditionally linked to in vivo models, to examine virulence factors, the host's antifungal immunity, and the sensitivity and efficacy of antifungal compounds (Hohl, 2014). For this purpose, mammalians are the most used models, and among them, rodents are considered the gold standard for studying pathogenesis and efficacy of antifungal drugs (Chamilos et al., 2007; Binder et al., 2016). Mice are often used to assess the Sporothrix spp. virulence using different animal strains, such as BALB/c, C57BL/6, and OF-1; and experimental infection techniques, like intraperitoneal, intravenous, and subcutaneous fungal delivery (Arrillaga-Moncrieff et al., 2009; Carlos et al., 2009; Della Terra et al., 2017). The main advantages of mice models are that their reproductive cycle is relatively short and litters contain several members, allowing the use of various animals per experimental group; the animal manipulation and dissection are well-known and easy to replicate; and genetically modified strains are currently available, allowing the assessment of particular genes in the host-fungus interaction (Clemons and Stevens, 2005). Rats also represent a viable option to study fungal pathogenesis, with advantages similar to those found in mice, but with the main disadvantage that the animal housing is relatively more expensive when compared to mice (Chamilos et al., 2007). In the last century, the use of other mammals, such as guinea pigs and cats was common in clinical investigations, but nowadays the standard choice usually is a murine model (Orofino-Costa et al., 2017). Moreover, the use of animal models was important in demonstrating the different virulence attributes of organisms that seemed to be morphologically similar or identical, that was the case of all the environmental isolates recovered from the biggest sporotrichosis outbreak occurring in New York in 1988. All of the isolates produced Sporothrix spp. anamorphs, characterized by conidia arranged in a sympodial form on the inflated apices of lateral conidiophores, but only those that produced melanized conidia and grew up at 37°C produced fatal infections in mice, supporting the mycological identification of S. schenckii in a time where DNA typing studies were scarce (Dixon et al., 1991, 1992).
The medically relevant Sporothrix species can generate conidia, hyphae, and yeast-like cells (López-Romero et al., 2011; Lopes-Bezerra et al., 2018a), and the fungal morphology used for host inoculation, along with the infection route, and the animal genetic background, should be taken into account during data interpretation. As an example, it was reported that phagocytic receptors on macrophages distinguish between yeast and conidia morphotypes, with different outcomes in the response of these immune cells (Guzman-Beltran et al., 2012). Conidia are often used to analyze the in vivo dimorphism to yeast-like cells, but since the latter morphology is considered the pathogenic and invasive morphology, some researcher groups prefer the inoculation of this fungal morphology. This is an ongoing debate in this area that remains to be solved. In addition, instead of cells, soluble antigenic preparations from S. schenckii can be isolated and used to inoculate mice (Carlos et al., 1992; Huang et al., 2021). External factors such as culture media, cell longevity, and maintenance conditions should also be considered during the analysis of the host-fungus interaction since they have been reported to influence cell wall composition, fungal morphogenesis, and virulence (Lopes-Bezerra et al., 2018b; Lozoya-Pérez et al., 2020).
The phenotypic and genomic analyses have demonstrated that Sporothrix spp. has different virulence degrees, which are associated with particular clinical forms (Arrillaga-Moncrieff et al., 2009). In the mouse model of systemic sporotrichosis, S. brasiliensis is the most virulent species of the pathogenic clade, and is associated with several clinical manifestations and high tissue burdens in animal models; while S. schenckii generally shows moderate virulence, causing mostly chronic subcutaneous infections (Arrillaga-Moncrieff et al., 2009; Lopes-Bezerra et al., 2018a). S. globosa is described as a low virulence species and is mainly associated with lymphocutaneous infections (Cruz Choappa et al., 2016).
The tissue from which a Sporothrix strain is isolated may also be involved in fungal virulence. It has been described that S. schenckii strains isolated from lymphocutaneous lesions showed more multiplication in the mouse internal organs than strains isolated from fixed cutaneous lesions (Kwon-Chung, 1979). Accordingly, it has also been reported that isolates from cutaneous lesions only produced footpad swelling in mice (Tachibana et al., 1998), and S. schenckii strains isolated from human lymphocutaneous sporotrichosis caused a disseminated infection in the murine model (de Capriles et al., 1993). Sporothrix isolates intrinsic factors such as pigmentation, capacity to grow at 37°C, and ergosterol peroxide production, influence the virulence in mice (Arrillaga-Moncrieff et al., 2009; Carlos et al., 2009). Melanin protects against phagocytosis and oxidative killing, and it has recently been reported that this pigment can also inhibit the major histocompatibility complex expression on the macrophage surface in vivo (Almeida-Paes et al., 2012; Song et al., 2021). Adhesion to fibronectin is another important Sporothrix virulence factor. Strains with more adherence to the extracellular matrix components are the most virulent in vivo (Teixeira et al., 2009). Surface components of the S. schenckii wall have been characterized, and their relevance in pathogenesis has been described. Peptidorhamnomannan is an S. schenckii cell wall glycoconjugate composed of rhamnose, mannose, protein, and polysaccharides containing galactose with antigenic capacity, making it important for pathogenesis (Lopes-Bezerra, 2011). The O-linked oligosaccharides are also cell wall components that are highly immunogenic and possibly involved during host colonization (Lopes Alves et al., 1994).
In this context, it has been reported that even when using the same strain, the virulence degree can vary according to the route of infection, demonstrating that the intravenous route favors systemic infections and the subcutaneous route mimics the natural infection produced by cat bites or scratches (Brito et al., 2007). In addition, external factors could influence virulence as well, such as the growing conditions of fungal biomass; S. schenckii yeast-like cells cultivated in a rich medium such as brain-heart infusion were more virulent on mice than cells grown in poorer culture medium (Teixeira et al., 2010; see Table 1).
Table 1. Application of mammalian, invertebrate, and ex vivo models in the study of the Sporothrix-host interaction.
Systemic and Peritoneal Models of Sporotrichosis in Mice
In general terms, in an experimental model of systemic sporotrichosis, mice can be inoculated intraperitoneally or intravenously either in the tail vein or in the retro-orbital plexus (Tachibana et al., 1998; Fernandes et al., 1999). For a disseminated fungal infection, the criterion for virulence is usually the measurement of median survival times; however, after infection, inactivity signs and weight measurements can be daily recorded, and blood samples can be collected to evaluate the levels of circulating immune mediators such as cytokines and antibodies. The fungal load can also be determined by quantifying the colony-forming units in the kidneys, lungs, spleen, brain, testicles, and popliteal lymph nodes; and histopathological studies in different organs can be assessed as well (Arrillaga-Moncrieff et al., 2009; Fernández-Silva et al., 2012b; Manente et al., 2018).
Most of our knowledge about the host immune response against Sporothrix spp. has been determined using the model of systemic infection in mice (Martinez-Alvarez et al., 2014). The importance of the host immune responses for the sporotrichosis control is evidenced by the higher fungal colonization and dissemination in the immunosuppressed mouse model and immunocompromised patients (Batista-Duharte et al., 2018a; Manente et al., 2018). Thus, the comparative study of systemic sporotrichosis using both immunocompetent and immunosuppressed animals may contribute to understanding the disease immunopathogenesis, searching for new prophylactic or therapeutic options, and evaluating xenobiotics effects on the infection etiological agent. To understand the immunological mechanisms involved in sporotrichosis prevention and control, mice were inoculated in the footpad with S. schenckii cell wall soluble antigens. Eight weeks after inoculation, it was observed an increase of mononuclear cells, as well as paw thickening, which could be due to a delayed hypersensitivity reaction (Carlos et al., 1992). Given that high titers of antigens were used in this experiment, immunological tolerance might be induced in the host, being reflected in a depression of cellular immunity (Carlos et al., 1992). Moreover, it has been already reported the importance of cell-mediated immunity in the protection against S. schenckii infection (Shiraishi et al., 1992). Experiments using nude mice also support the importance of CD4+ T cell-mediated immunity against S. schenckii. Congenitally athymic mice were found to be more susceptible to intravenous infection with S. schenckii than normal mice, based on lethality and measurement of viable yeast-like cells in the liver after 7 days of infection (Dickerson et al., 1983; Kajiwara et al., 2004). In line with these observations, thymus transplantation from normal to nude mice conferred a significant degree of protection, suggesting that thymus-derived cells play an important role in the resistance against sporotrichosis (Dickerson et al., 1983). Nude mice intratestically infected had a higher fungal load in testis than wild-type animals, supporting the idea that T cells play a role in the inhibition of fungal growth in organs (Shiraishi et al., 1992).
As mentioned, one advantage of murine models is the availability of knockout mice in several immunity-related genes, and thus, it is possible to assess their contribution during the establishment of the infection caused by Sporothrix spp. When the responses of wild-type and tlr4 −/− knockout mice against intraperitoneally inoculated S. schenckii cells were compared, it was found that nitric oxide, tumor necrosis factor-alpha (TNF-α), and interleukin (IL)-10 levels were significantly reduced in the knockout mice, suggesting a possible role of this receptor in the recognition of S. schenckii yeast-like cells (Sassá et al., 2009). These observations were supported by infection assays in C3H/HeJ mice, which have a natural point mutation in the TLR4 gene, finding that they were deficient in the production of antimicrobial mediators, such as H2O2, when challenged with lipid extracts from S. schenckii yeast-like cells (Carlos et al., 2009). The TLR4 role during S. brasiliensis sensing has also been assessed. The tlr4 −/− knockout mice infected with this fungal species showed high levels of fungal burden and deficient cytokine production after 14 days of infection when compared with wild-type mice, indicating that this receptor is also relevant for this pathogen control (Rossato et al., 2019). The TLR2 contribution to the innate immune response against S. schenckii has also been investigated. The tlr2 -/- knockout mice showed a lower percentage of macrophages with phagocytized yeasts-like cells when compared with cells from wild-type animals (Negrini Tde et al., 2013).
In addition to TLR2 and TLR4, dectin-1 plays an important role in the Sporothrix recognition. The fungal β-1,3-glucan recognition by dectin-1 induces a proinflammatory response and neutrophils and macrophages activation (Taylor et al., 2007). After inoculation of S. schenckii yeast-like cells in the peritoneal space and a follow up of 2 weeks, peritoneal macrophages showed that dectin-1 expression was significantly upregulated, as well as cytokine production, suggesting an important role for this receptor during the establishment of an immune response during sporotrichosis (Jellmayer et al., 2017).
Like other pathogens, the S. schenckii cell wall contains polysaccharides, and their abundance and distribution within the wall have important roles in modulating the animal immune response (Lozoya-Pérez et al., 2020; Villalobos-Duno et al., 2021). The effect of S. schenckii chitin-rich heteroglycan on the immune response was assessed by histopathological analyses of skin lesions in a mouse model of sporotrichosis, and the phagocytic function and cytokine production by peritoneal macrophages were evaluated (Huang et al., 2021). Following the inoculation of chitin in BALB/c mice, the granulomatous inflammation was reduced within 5 weeks, and fungal phagocytosis and TNF-α production were significantly improved (Huang et al., 2021).
A 70-kDa cell wall glycoprotein has been reported as an antigen that induces high antibody titers, being specially recognized by IgG1 and IgG3 in murine models of systemic sporotrichosis (Nascimento and Almeida, 2005). Moreover, this protein facilitates yeast-like cell adhesion to the mouse tail dermis, suggesting a role in S. schenckii pathogenesis (Ruiz-Baca et al., 2009). Passive immunization of mice with a monoclonal anti-Gp70 antibody before inoculation of a lethal dose of S. schenckii showed a significant reduction of colony-forming units in the spleen and liver of immunized mice, possibly due to an antibody-driven inhibition of S. schenckii adhesion to host tissues (Nascimento et al., 2008). The monoclonal antibody was protective regardless of the Sporothrix species, as demonstrated by its effectivity in intraperitoneally infected mice with S. brasiliensis (de Almeida et al., 2015). However, antibody humanization was necessary to avoid the production of anti-murine antibodies in patients (de Almeida et al., 2017). This monoclonal antibody showed efficiency in the control of sporotrichosis in vitro and in vivo, representing a great alternative for treatment in humans (de Almeida et al., 2017).
In addition, the model of systemic infection in mice can contribute to the study of antifungal drugs against Sporothrix. The conventional approach to treat sporotrichosis includes administration of potassium iodide, amphotericin B, azoles (itraconazole, fluconazole), or terbinafine (Orofino-Costa et al., 2017). Previous studies suggested that amphotericin B can prevent death in mice with disseminated infection and reduce the number of clinical lesions (Tsubura and Schwarz, 1961; Kan and Bennett, 1988). This antifungal drug evoked the best reduction of animal mortality without any adverse effects, and better performance when compared with azoles, which significantly reduced animal mortality, without healing the tail and paw lesions were persistent in almost every mouse (Kan and Bennett, 1988). Posaconazole has also been studied in vivo to treat infections caused by either S. schenckii or S. brasiliensis, using a murine model of disseminated sporotrichosis, demonstrating a good efficacy in fungal burden reduction without toxic effects (Fernández-Silva et al., 2012a). A later study reported the in vitro synergistic combination of posaconazole with amphotericin B to treat murine sporotrichosis, showing that administration of both drugs to mice with systemic infection led to 100% survival rates (Mario et al., 2015).
Both the systemic and peritoneal infections in murine models have contributed to the understanding of the mechanisms involved in the host immune response during sporotrichosis, establishing the foundations for the understanding of the Sporothrix-immunity interaction in other mammalians, such as human beings.
Subcutaneous Model of Sporotrichosis in Mice
Since sporotrichosis is the most frequent subcutaneous mycosis in Latin America (Chakrabarti et al., 2015), it is essential to understand the mechanisms behind Sporothrix spp. pathogenesis in the subcutaneous tissue. The subcutaneous inoculation reflects the natural infection route for these fungal species and takes into account the traumatic inoculation with soil and plant debris contaminated or the animal-driven implantation. The subcutaneous infection in mice has been carried out in the hind footpad or the dorsal sacral region, using either conidia or yeast-like cells (Tachibana et al., 1999; Castro et al., 2013). The subcutaneous infection is followed up by weight measurement, footpad thickness, the evolution of the primary skin lesion, and the development of secondary lesions (de Almeida et al., 2018). The progression from subcutaneous to a systemic infection was demonstrated in BALB/c mice subcutaneously inoculated into the left hind footpad with S. schenckii yeast-like cells. After this challenge, animals showed weight loss, cutaneous lesions, inactivity, and different survival rates, mimicking the human disease (Brito et al., 2007). Histological analyses revealed inflammatory infiltrates and granuloma in the liver and an inflammatory reaction in the inoculation area (Brito et al., 2007).
It is well-established that S. brasiliensis is related to the zoonotic transmission of sporotrichosis and the emergence of severe cases of this disease (Rodrigues et al., 2016). To investigate whether S. schenckii and S. brasiliensis share similar virulence factors and whether they have differences in pathogenicity, clinical strains of both species were subcutaneously inoculated in mice and the disease progression was followed by the evolution of the primary skin lesion, secondary lesions development, and dissemination to spleen and lungs (Castro et al., 2013). The study showed that S. brasiliensis clinical isolates had increased pathogenicity when compared with S. schenckii, with persistent skin lesions in mice and a higher ability to disseminate, with significant fungal load observed in the lungs and spleen, that lead to 100% mortality of infected mice (Castro et al., 2013). In agreement with these results, another study showed that subcutaneously challenged mice with S. brasiliensis developed lesions in the footpad 1 week post-infection, showing an ulcerous-crust appearance similar to that seen in both human and animal sporotrichosis (Della Terra et al., 2017). In addition, it was shown that this pathogen can disseminate across the central nervous system, even when a subcutaneous route is used (Della Terra et al., 2017).
In this context, differences between immune responses against S. schenckii and S. brasiliensis have been reported. The role of cellular immune responses in sporotrichosis was investigated by evaluating T helper, and T regulatory cells (Tregs), a subset of T lymphocytes with a FoxP3+ phenotype. Either S. schenckii or S. brasiliensis were subcutaneously inoculated in the dorsal sacral region of mice, and infection progression was monitored by observing fungal load in skin lesions, spleen, and liver, thus evaluating both local and systemic infection. It was demonstrated that S. brasiliensis developed more extensive local lesions and was also more efficient in colonizing organs than S. schenckii, confirming a higher virulence for S. brasiliensis (Batista-Duharte et al., 2018b). This difference was related to the cellular immune response: while S. schenckii infection was controlled by T helper cells (Th1 and Th17) and associated with late Tregs response, the S. brasiliensis infection evoked poor Th1 response at early stages of infection, with higher Th17 and Tregs in the advanced phase (Batista-Duharte et al., 2018b). These results led to hypothesize that Tregs probably promotes a deleterious effect in the protective immune response mediated by Th1 lymphocytes while promoting a compensatory Th17 response. To elucidate the role of Tregs cells, DEREG (DEpletion of REGulatory T cells) mice were used to establish a subcutaneous infection caused by S. schenckii. These mice express proteins that are under the control of the FoxP3 locus, allowing the depletion of FoxP3+ Tregs at any stage of the disease (Batista-Duharte et al., 2020). Tregs depletion led to an enhanced Th1 response, whereas no significant differences were seen in the Th17 population between depleted and no depleted-Tregs animal groups (Batista-Duharte et al., 2020). In the late infection stage, Tregs depletion correlated with a beneficial effect in fungal clearance, suggesting that Th1 and Th17 stimulation after Tregs deletion helped to a faster fungal elimination (Batista-Duharte et al., 2020). As in the systemic and intraperitoneal infection, cellular and humoral immune responses triggered upon Sporothrix infection into the subcutaneous tissue may play important roles in the sporotrichosis development and severity (Verdan et al., 2012). Animals infected with S. brasiliensis induced antibody production against a wide diversity of antigens during the subcutaneous infection in mice, and these antibodies showed high cross-reactivity levels when tested against S. schenckii antigenic preparations, suggesting conservation of epitopes in both species (Della Terra et al., 2017).
Because of all the above-described examples, it is clear that the subcutaneous model of sporotrichosis in mice can serve as a reference to study Sporothrix pathogenesis and host immune responses, contributing to the understanding of the mechanisms involved in the subcutaneous infection.
Other Mammals
In addition to mice, other mammals such as rats, rabbits, hamsters, guinea pigs, and cats have been used as a host for experimental infections with S. schenckii (Charoenvit and Taylor, 1979). Rats can be intraperitoneally infected with S. schenckii, generating a systemic infection that allows cytokines quantification and histological analyses of organs such as the liver, spleen, and testicles (Castro et al., 2016, 2017). The immune anti-Sporothrix response developed by the host can also be investigated in rats. Mast cells are a source of histamine and proteases and are important effector cells in the protective immunity against pathogens (Saluja et al., 2012). Romo Lozano et al. aimed to evaluate the in vitro mast cells response to S. schenckii yeasts-like cells, using mast cells from Wistar rats peritoneal exudates. These fungal cells stimulated morphological changes in mast cells, which are related to activation, and produced increased levels of TNF-α and IL-6 (Romo-Lozano et al., 2012, 2014). It is established that oxidative stress plays an important role in many fungal infections (Pohanka, 2013). In a systemic model of sporotrichosis in rats, it was found that lipid peroxidation, catalase, and superoxide dismutase activities were significantly increased in infected animals when compared to control healthy rats (Castro et al., 2017). These results strongly suggest that the intense inflammatory response in sporotrichosis could be due to a redox imbalance, causing high amounts of reactive oxygen species that increase tissue damage, as seen in infected rats, which developed granulomatous lesions in the inoculation sites (Castro et al., 2017).
Rats are a useful model to assess the antifungal activity of compounds against sporotrichosis. Terbinafine and itraconazole have demonstrated effectiveness in reducing clinical lesions in Sporothrix-infected rats, such as nodular and whitish lesions on the spleen, liver, and testicles, suggesting efficacy to treat systemic sporotrichosis (Meinerz et al., 2008).
Guinea pigs had been used in the past to study antifungal compounds against sporotrichosis (Van Cutsem et al., 1987). However, there are no reports of using this model to assess S. schenckii pathogenesis. Nevertheless, this model is frequently used in the investigation of Candida albicans and Cryptococcus neoformans virulence (Murphy et al., 1974; Sohnle and Kirkpatrick, 1977; Odds et al., 2000). The lack of use of this model to study sporotrichosis might be due to the availability of other in vivo models that have more advantages, such as easier manipulation and the examination of larger animal groups.
Experimental sporotrichosis in cats can resemble in many ways human infection. Once animals are inoculated, they develop primary local lesions, followed by secondary lesions in the lymphatic nodes, like in human sporotrichosis, in which lesions frequently extend to lymphatic vessels (Barbee et al., 1977). Cats are important models in the study of antifungal drugs for sporotrichosis treatment. Itraconazole and ketoconazole had been tested in vivo in sick cats to determine the effectiveness and safety, and have shown good responses to the antifungal treatment (Schubach et al., 2004). However, the occurrence of adverse effects might happen during treatment, as seen in the in vivo assays, where anorexia, vomiting, and diarrhea were frequent in the tested cats (Schubach et al., 2004; Pereira et al., 2010).
Even though it is not regarded as an experimental model of sporotrichosis, the study of naturally infected cats is useful in epidemiological studies. For example, the study of 300 cats, including healthy and Sporothrix-infected animals showed that healthy cats have a minor role in sporotrichosis transmission (Macêdo-Sales et al., 2018).
Invertebrate Models to Study Sporotrichosis
As mentioned before, animal models are a key tool for virulence evaluation of human pathogenic fungi, being the murine model the gold standard. However, some concerns about ethical issues and animal welfare have motivated the limitation of animal experimentation and the search for alternative models, such as invertebrates, where ethical concerns are less restrictive and because of their life cycle, several individuals can be included in the experimental groups, strengthening the statistical power (Jacobsen, 2014; Singulani et al., 2018). Invertebrate models, such as Galleria mellonella, Tenebrio molitor, and Acanthamoeba castellani have been successfully used to study the Sporothrix-host interaction (see Table 1).
Galleria mellonella
Larva of the wax moth, G. mellonella, has been extensively used in the study of human fungal pathogens, such as Aspergillus fumigatus, Candida spp., Cryptococcus spp., Paracoccidioides spp., Histoplasma capsulatum, and Sporothrix spp. (Brennan et al., 2002; Mylonakis, 2008; Clavijo-Giraldo et al., 2016; Navarro-Arias et al., 2016; Perez-Garcia et al., 2016; Hernandez-Chavez et al., 2018, 2019; Singulani et al., 2018; Garcia-Carnero et al., 2020). This model has several advantages when compared to mammals, such as easier manipulation, the requirement of simple facilities for housing and breeding, cheaper to purchase and to maintain, they can be kept at 37°C and the fact that they can generate results in just a couple of weeks (Mylonakis, 2008; Pereira et al., 2018; Garcia-Carnero et al., 2020). In addition, the G. mellonella immune system is structurally and functionally similar to mammalian innate immunity (Kavanagh and Reeves, 2004; Malavia et al., 2020). Virulence in this model can be measured easily by the melanization and subsequent insect death (Mylonakis, 2008; Pereira et al., 2018). Also, changes in the hemocyte density, phenoloxidase activity, melanization, and measurement of free lactate dehydrogenase are used as indicative of virulence and the immune response against the fungal pathogen (Bergin et al., 2006; Kavanagh and Sheehan, 2018; Garcia-Carnero et al., 2020).
The G. mellonella model is suitable for the study of the Sporothrix species, as highlighted in different reports. First, it has been demonstrated that larva infection with conidia, germlings, and yeast-like cells from S. schenckii and S. brasiliensis killed the larvae in a dose-dependent manner, being the yeast-like morphology the one capable to reproduce the result generated in mice (Clavijo-Giraldo et al., 2016). In addition, it was observed that the concentration 1 x 105 cells/μL caused a difference in the mortality rate, while no difference was observed when higher fungal loads were inoculated, which could be explained by an exaggerated immune response at high fungal concentrations, being a detrimental factor for the animals' fitness (Clavijo-Giraldo et al., 2016). Similar to the mammalian host, the ideal temperature to maintain the yeast-like morphology in these experiments is 37°C (Clavijo-Giraldo et al., 2016). Finally, it has been observed that infection with S. brasiliensis yeast-like cells was more aggressive when compared with animals inoculated with S. schenckii, similar to what has been reported in the murine model (Clavijo-Giraldo et al., 2016; Della Terra et al., 2017). The virulence of different strains from S. schenckii and S. brasiliensis was also evaluated in this model. The already reported S. schenckii low virulent strains 1099-18 ATCC MYA 4821, Ss39, and Ss47, and the virulent strain SS-B02 were used to infect larvae and it was observed that the SS-B02 and Ss39 strains were the most virulent ones in G. mellonella (Clavijo-Giraldo et al., 2016). The strain Ss39 had been reported to be a low virulent strain in mice, and the fact that this strain showed a higher virulence in larvae could be explained by the inoculum preparation in different carbon sources (Clavijo-Giraldo et al., 2016; Lozoya-Pérez et al., 2020). In addition, similar experiments were performed with S. brasiliensis, and it was observed that the strains 5110 ATCC MYA 4823 and HUPE 114158 were the most virulent in G. mellonella, while HUPE 114500 and UFTM01 had mild virulence, these results were similar to those generated in the subcutaneous model of sporotrichosis in mice (Clavijo-Giraldo et al., 2016).
This model was also used to evaluate the virulence of S. schenckii mutants. Mutants with different degrees of OCH1 silencing, a Golgi α1,6-mannosyltransferase with an important role in the N-linked glycans synthesis, had a virulence attenuation in both G. mellonella and mice (Lozoya-Perez et al., 2019). In addition, silenced mutant strains in RlmD, a gene that encodes an epimerase/reductase enzyme involved in the UPD-rhamnose synthesis, showed virulence attenuation in G. mellonella and induced low cytotoxicity, hemocyte, and phenoloxidase levels (Tamez-Castrellón et al., 2021). Since similar fungal burdens were found in the hemolymph of both wild-type and mutant strains, the reduction in the mortality rate was associated with changes in the virulence rather than the ability of mutant cells to adapt to the host milieu (Tamez-Castrellón et al., 2021). Mutant cells that express the green fluorescent protein but with no gene silencing involved have also been assessed in this alternative model of sporotrichosis (Lozoya-Perez et al., 2018).
The effect of the culture medium to generate fungal biomass on virulence was also tested using G. mellonella larvae. The kill curves for S.schenckii, S. brasiliensis, and S. globosa were similar to those reported in mice, being S. brasiliensis the most virulent species, followed by S. schenckii and S. globosa, when cells were grown in YPD or brain-heart infusion (Lozoya-Pérez et al., 2020). It was also found that carbon or nitrogen limitation impaired S. schenckii and S. brasiliensis abilities to kill the larvae, but not for S. globosa (Lozoya-Pérez et al., 2020). This observation was linked to an increase in hemocyte countings, phenoloxidase activity, and lower cytotoxicity, as a consequence of alterations in cell wall composition and organization in S. schenckii and S. brasiliensis, with a significant increment in the β-1,3-glucan at the cell surface (Lozoya-Pérez et al., 2020). This was not observed for S. globosa, since this species has naturally higher levels of β-1,3-glucans exposed at the cell surface, regardless of the culture medium to prepare yeast-like cells (Lozoya-Pérez et al., 2020). The exposure of this cell wall polysaccharide increased the ability of the insect hemocytes to uptake and degrade fungal cells, explaining the changes in virulence of cells growing in limited carbon and nitrogen conditions (Lozoya-Pérez et al., 2020).
In G. mellonella, like in other insects, the immunological priming is a response similar to the immunological memory found in mammals (Contreras-Garduño et al., 2015). S. schenckii Gp70 was heterologously expressed in bacteria and the recombinant protein ability to induce immunological priming was assessed (Martinez-Alvarez et al., 2019). When G. mellonella larvae were inoculated with increasing concentrations of recombinant Gp70 before a lethal challenge with S. schenckii, the mortality rate decreased. Also, an increment in the hemocyte population and phenoloxidase activity was observed with concentrations of 40 μg recombinant Gp70 and higher (Martinez-Alvarez et al., 2019). Similar results were recently reported for Hsp60 and Pap1, proteins that are part of cell wall peptidorhamnomannan (García-Carnero et al., 2021). Besides the ability of the recombinant versions of these proteins to induce immunological priming, preincubation of yeast-like cells with anti-Hsp60 or anti-Pap1 antibodies resulted in cells incapable of killing G. mellonella, indicating a relevant role of both proteins in the S. schenckii-G. mellonella interaction (García-Carnero et al., 2021).
This model has also been used to assess the effect of antifungal drugs on Sporothrix spp. Itraconazole-loaded nanostructured lipid carriers showed no toxicity for larvae and improved the survival rate of insects infected with S. brasiliensis yeast-like cells, with 100% of animals surviving at the end of the 5-day observation period (Passos et al., 2020). The effect of buparvaquone, an antiprotozoal hydroxynaphthoquinone drug, on S. brasiliensis-induced infection was also assessed. Larvae inoculated with a single dose of 5 mg/kg buparvaquone had an increased survival rate than the control group, and the drug performance was even better than that observed with itraconazole (Borba-Santos et al., 2021).
Tenebrio molitor
The mealworm beetle, T. molitor, is another popular invertebrate model that has been used for the study of different pathogenic fungi, such as C. albicans, C. neoformans, Fonsecaea pedrosoi, and Fonsecaea monophora (de Souza et al., 2015; Canteri de Souza et al., 2018; Fornari et al., 2018). This model shares all the advantages already mentioned for G. mellonella, but in addition, it generates bigger larvae which make it easier to manipulate and obtain higher hemolymph volumes to analyze different physiological parameters (Canteri de Souza et al., 2018; Vigneron et al., 2019). When this model was assessed for the analysis of S. schenckii, S. brasiliensis, and S. globosa infection, the same virulence pattern as for the mice model and G. mellonella was observed, being S. brasiliensis the most virulent species and S. globosa the least (Lozoya-Perez et al., 2021). These findings were validated using mutants with different virulence degrees, observing that low virulent strains stimulated low cytotoxicity and immune response (phenoloxidase activity and hemocyte counting), and therefore a longer larvae survival; while the highly virulent strains caused an exacerbated immune response, with high hemocytes levels. In addition, immunological priming that protected the larvae was observed when the recombinant Gp70 was inoculated before a lethal challenge with S. schenckii (Lozoya-Perez et al., 2021). All of these results suggest that T. molitor is a good model as G. mellonella for the evaluation of Sporothrix spp. virulence.
Acanthamoeba castellanii
A. castellanii is an environmental soil amoeba that feeds on bacteria and fungi by phagocytosis (Chambers and Thompson, 1976). This non-conventional model was also found to be useful for the study of Blastomyces dermatitidis, H. capsulatum, and Sporothrix virulence, due to its phagocytic features, which can be compared to those of mammalian macrophages (Steenbergen et al., 2004; Singulani et al., 2018). It was reported that the interaction between S. schenckii and A. castellanii caused amoeba death due to the fungal growth, which uses A. castellanii as a nutritional source under starvation conditions (Steenbergen et al., 2004). It was also observed that S. schenckii grew as hypha and pseudohyphae inside the amoeba, very similar to what has been observed in macrophages, and electron microscopy revealed that the fungus gets enclosed in a membrane-bound vacuole after phagocytosis (Steenbergen et al., 2004). In addition, when phagocytosis assays were performed with macrophages and A. castellanii, the rate of yeast-like cells internalization was similar for both models (Steenbergen et al., 2004).
Ex vivo Models for the Sporothrix spp.-Host Interaction
The establishment of protocols aiming to reduce animal use in experimentation has become a worldwide trend, and currently, there has been an emphasis on the application of the 3Rs, that is, replacement, reduction, and refinement, which can be beneficial for good science, as well as for animal welfare (MacArthur Clark, 2018; Brilhante et al., 2021). The ex vivo models refer to the use of living tissues or cells, which are recovered from an organism, to apply them in experiments to be carried out in artificial environments (Ohnemus et al., 2008; Maciel Quatrin et al., 2019). These models maintain the cell types and the format of the infected tissues without the need of using animals (Lossi and Merighi, 2018). Ex vivo experimental models, such as endothelial cells, immune cells, and cell lines, can simulate infectious processes occurring in vivo and are of great importance to evaluate new drugs, learn more about pathogenesis, virulence, immune response, and the fungal ability to adhere and form biofilms (Ohnemus et al., 2008; Maciel Quatrin et al., 2019; Brilhante et al., 2021; see Table 1).
Endothelial Cells
Many fungi that cause invasive diseases invade host epithelial cells, affecting the mucosa and subsequently invading endothelial cells during the dissemination stage (Filler and Sheppard, 2006). C. albicans and C. neoformans adhere to and penetrate the endothelial compartment, suggesting that the endothelium is an important barrier that must be overcome by pathogens (Klotz, 1992). Little is known about this interaction during sporotrichosis, but some studies support that Sporothrix spp. also crosses this barrier (Lima et al., 1999; Figueiredo et al., 2004). Thus, implementing the ex vivo use of endothelial cells could help to understand this phenomenon. Human umbilical vein endothelial cells have been used to determine the relevance of these cells during S. schenckii infections (Figueiredo et al., 2004). The analyses indicated that the yeast-like cells are in the interendothelial junctions, internalized within endocytic vacuoles after 2 h of interaction, and 24 h post-interaction no damage was observed in the endothelial cells (Figueiredo et al., 2004), meaning that S. schenckii is able to adhere and invade these cells without affecting cell viability.
Macrophages
Currently, using different primary immune cells it is possible to assess the contribution of immune effectors in the Sporothrix-host interaction. Macrophages, as innate immune cells, depend on pattern recognition receptors to engage with pathogens and are one of the most important defense lines against fungal pathogens, including Sporothrix spp. (Netea et al., 2008; Carlos et al., 2009; Martinez-Alvarez et al., 2014). Pattern recognition receptors in macrophages such as TLRs, the family of nucleotide-binding oligomerization domain-like receptors (NOD and NLR), the NLRP3 domain, and C-type lectins, like dectin-1, have been studied during the macrophage-Sporothix spp. interplay. Ex vivo tests with peritoneal macrophages have shown a correlation between the TLR4 expression and the secretion of pro- and anti-inflammatory mediators, such TNFα and IL-10, respectively, during sporotrichosis (Sassá et al., 2009). Interestingly, even though the Sporothrix cell wall contains significant mannose levels (Martinez-Alvarez et al., 2017; Lopes-Bezerra et al., 2018b; Villalobos-Duno et al., 2021), it has been shown that mannose receptor has a minor contribution in the cytokine production in ex vivo models (Martinez-Alvarez et al., 2017). In an ex vivo sporotrichosis model using peritoneal exudate cells challenged with S. schenckii cell wall peptide-polysaccharide complex, M2 macrophages were the most predominant population, and expressed arginase-I activity peaks as well as IL-10 and transforming growth factor-beta (Alegranci et al., 2013).
Macrophages derived from human peripheral blood mononuclear cells (PBMCs), allow determining the interaction of pathogens with the host, and the contribution of the phagocytic processes in the defense mechanisms. This model has been used to analyze the relevance of S. schenckii protein glycosylation to pathogenesis. Loss of the N-linked glycan outer chain, by OCH1 silencing, led to significant changes in the cell wall composition and structure, which negatively affected phagocytosis by PBMC-derived macrophages (Lozoya-Perez et al., 2019). Similar results have also been found in C. albicans and other Candida species (Cambi et al., 2008; McKenzie et al., 2010; Navarro-Arias et al., 2016; Perez-Garcia et al., 2016; Gonzalez-Hernandez et al., 2017; Hernandez-Chavez et al., 2019). Moreover, the S. schenckii-PBMC-derived macrophage interaction was significantly affected by the RlmD silencing, a key gene in the UDP-rhamnose synthesis (Tamez-Castrellón et al., 2021). These analyses led to the observation that rhamnose immune sensing is a TLR4-dependent process (Tamez-Castrellón et al., 2021).
Human Peripheral Blood Mononuclear Cells
Many works have shown that antifungal immunity requires the orchestration of both innate and adaptive immune responses. PBMCs represent an attractive source of innate and adaptive immune cells because they can be easily obtained from patients and healthy donors. One disadvantage of working with these cells is that they are sensitive to variables such as temperature, stimulation, and collection time (Acosta Davila and Hernandez De Los Rios, 2019). This model has been used to assess the relevance of the S. schenckii and S. brasiliensis cell wall composition during the interaction with innate immune cells (Martinez-Alvarez et al., 2017). By measuring the stimulation of both pro- and anti-inflammatory cytokines by PBMCs, it was established that S. schenckii stimulates higher levels of pro-inflammatory cytokines, compared to S. brasiliensis, which stimulated higher IL-10 levels (Martinez-Alvarez et al., 2017). The dectin-1 receptor was key for cytokine production and TLR2 and TLR4 participated in the detection of both Sporothrix species (Martinez-Alvarez et al., 2017). From these results, it is possible to suggest that in the case of S. brasiliensis, a pro-inflammatory scenario was less stimulated by conidia, and as a consequence, this fungus has a better ability to colonize tissues and establish the infective process (Martinez-Alvarez et al., 2017). This could help yeast-like cells to spread easily within the lymphatic system and deep organs (Martinez-Alvarez et al., 2017). In addition, it has been found that there are other soluble receptors involved in the recognition of Sporothrix pathogenic species, such as PTX3. Secretion of this receptor facilitates the deposition of some complement system components, helping in the pathogen elimination. It was also demonstrated that CR3, a complement receptor expressed in macrophages, directly recognizes peptidorhamnomannan from both S. schenckii and S. brasiliensis (Neves et al., 2021). This model has also been used to assess the contribution of protein glycosylation to the S. schenckii-immune effectors interaction. Loss of proper N-linked glycosylation or rhamnosylation led to changes in the ability to stimulate TNFα, IL-1β, IL-6, and IL-10 by PBMCs (Lozoya-Perez et al., 2019; Tamez-Castrellón et al., 2021).
Mast Cells
Mast cells are a useful tool to elucidate the role of cutaneous defense mechanisms in sporotrichosis. When bone-marrow-derived mast cells were incubated with S. schenckii yeast-like cells no cell degranulation was observed, but there was an increase in IL-6 and TNFα stimulation, an observation that fits well with the in vivo model of sporotrichosis in rats, where the fungus promotes skin inflammation and overproduction of both cytokines, thus exacerbating cutaneous sporotrichosis (Romo-Lozano et al., 2014; Jiao et al., 2020). Mast cells can detect S. schenckii through TLR2, TLR4, and C-type receptors (Sandig and Bulfone-Paus, 2012).
Dendritic Cells
Dendritic cells (DCs) are known as specialized antigen-presenting cells and are an important innate immunity component that recognizes pathogen patterns and can activate an adaptive response, inducing antifungal immunity (Verdan et al., 2012; Ikeda et al., 2018). These cells can be used as ex vivo models to study Sporothrix spp. S. brasiliensis, like other fungal species, can release extracellular vesicles that interact with host cells and modulate the host's immune response (Ikeda et al., 2018). In particular, these extracellular vesicles induce an increase in the DCs phagocytosis index, and the production of IL-12 and TNFα (Ikeda et al., 2018), cytokines that perform very important immunoregulatory functions in the host defense. These characteristics can favor the fungus to mediate its establishment in the host. In addition, DCs are capable of recognizing information from fungal pathogens and translating it into differential T-cell responses. The mechanisms involved in the interaction of S. schenckii and DCs are not completely clear. S. schenckii yeast-like cells activated DCs and made them capable of triggering T cell responses, promoting IFN-γ production (Verdan et al., 2012). A yeast-derived exoantigen from this fungal species was capable of also activating DCs, to promote IFN-γ production, and in addition, the production of IL-17, with the consequent activation of a Th17 inflammatory response, demonstrating the plasticity of DCs in translating data associated with S. schenckii and its exoantigen into T-cell differential responses (Verdan et al., 2012).
Cell Lines
Cell lines have the advantage of being easy to use and providing highly reproducible results (Last et al., 2021). These can be cultured for a limited time or can be immortalized, and allow extensive control over growth conditions, O2 and CO2 saturation, temperature, pH, and nutrients (Last et al., 2021). There are many cell lines available, and represent a valuable resource that allows the study of conserved mechanisms in antifungal immune responses (Last et al., 2021), and the study of possible molecules with antifungal properties (Borba-Santos et al., 2020). For the latter, a Pathogen Box library for compounds with potential activity against S. brasiliensis and S. schenckii was analyzed and used to assess cytotoxicity potential (Borba-Santos et al., 2020). The most promising compounds, MMV102872, and iodoquinol were tested at various concentrations in the mammalian epithelial cell line LLC-MK2 (ATCC CCL-7), and the concentrations that caused 50% cytotoxicity of MMV102872 and iodoquinol were 8.7 M and 5 M, respectively, resulting in a high index of the selectivity of these compounds for S. schenckii and S. brasiliensis (Borba-Santos et al., 2020). Other cell lines have also been used for toxicity studies of these compounds, such as the HepG2 cell line, where reduced toxicity was also observed. These cell lines may be key to the study of compounds that may be candidates for the sporotrichosis treatment (Borba-Santos et al., 2020).
The human monocytic cell line THP-1 has also been used to determine phagocytosis of S. schenckii conidia, which were opsonized with human serum components. It was observed that the uptake of opsonized conidia stimulated ROS production, which led to fungal death (Guzman-Beltran et al., 2012). TNFα release was not stimulated by opsonized or non-opsonized conidia, but a differential cytokine production was observed when yeast-like cells were opsonized (Guzman-Beltran et al., 2012). These results obtained with the cell line have recently been confirmed using human monocyte-derived macrophages (Guzman Beltrán et al., 2021).
Epithelial cells are a model that can be used to evaluate the S. schenckii proteolytic activity (Sabanero López et al., 2018). By using the L929 epithelial cell line, it has been shown that S. schenckii has an extracellular proteolytic activity that allows the pathogen to penetrate and colonize the epithelium, through a paracellular route, and act on the cytoskeleton fibers during the infection process; suggesting a possible action of proteases on actin, altering the morphology and integrity of the epithelial cells (Schindler and Segal, 2008; Sabanero López et al., 2018). These effects on epithelial cells have also been observed using alveolar cells infected with A. fumigatus (Kogan et al., 2004).
Feline Claw Fragments
Cat scratches are a major event by which sporotrichosis can be transmitted. Sporothrix spp. has been isolated from cats, but there is a lack of knowledge about how this fungus colonizes felines and its ability to form biofilms (Gremião et al., 2017; Brilhante et al., 2021). For this reason, using ex vivo models such as cat's claw fragments, it has been possible to elucidate this information. Strains of S. brasiliensis, S. schenckii, S. globosa, and Sporothrix mexicana isolated from feline, human and environmental sources, were used to analyze fungal ability to form biofilms on cat's claw fragments, obtained from domestic cats of both sexes, older than 1 year, which did not show clinical signs of skin lesions (Brilhante et al., 2021). For S. brasiliensis and S. globosa, more characteristic and better-elaborated biofilms were formed, while in S. schenckii the biofilm formation consisted of weakly associated hyphae, which could indicate a lower amount of matrix material compared to the other species (Brilhante et al., 2021).
Concluding Remarks
The availability of different mouse strains, infection routes, and administration of pharmacotherapies represent great advantages for the murine models of sporotrichosis over other alternatives currently available. However, the strict ethical concerns and regulations, along with the requirement of large animal populations to be enrolled in sophisticated experimental approaches, have focused the attention of the specialized community on invertebrates and ex vivo models. Besides the vertebrate models already used to study Sporothrix spp. pathogenesis, zebrafish is a well-accepted model in medical mycology (Rosowski et al., 2018). Because of its particularities, live imaging to study the pathogen dissemination within the host and interaction with immune cells are advantages that offer these organisms over other vertebrates (Gomes and Mostowy, 2020). The invertebrates repertoire to experimentally study sporotrichosis can be expanded and include other popular alternative hosts to study fungal pathogenesis, such as Drosophila melanogaster and Caenorhabditis elegans (Chamilos et al., 2007). They have the advantage of having their genomes are already available, and for the case of flies, mutant strains in key immune regulators are available (Limmer et al., 2011). However, since these organisms are not viable at 37°C (Limmer et al., 2011; Singulani et al., 2018), it is unlikely that they might be useful to dissect Sporothrix pathogenesis and virulence. For the case of ex vivo experimental settings, 3D models represent an attractive and sophisticated alternative to study sporotrichosis in a system that resembles the natural architecture of the host infected tissues. Skin 3D models have been used to study several infectious diseases, including oral candidiasis (Tabatabaei et al., 2020). The basic skin model consists of dermal fibroblast and keratinocytes, followed by immune cells below the tissue, which can finally be infected with the fungal pathogen, which mimics fungal infections and allows the study of host-pathogen interaction (Kühbacher et al., 2017). This contrasts with the primary or cell line cultures that form monolayers. Even though this is a promising model to study sporotrichosis, the cost associated with this experimental approach and the inability to establish a systemic model of infection (Tabatabaei et al., 2020), are disadvantages that should be taken into consideration before implementation. The multi-organ-on-chip is another ex vivo alternative that remains to be used to study sporotrichosis. This alternative has been used to analyze the infection caused by C. albicans and provides the opportunity to know how fungal dissemination is carried out within organs (Last et al., 2021).
In summary, several alternatives to study the host-Sporothrix interaction are currently available, and there are factors to take into account before choosing the most appropriate one. Finally, the combination of models is likely to provide a robust dataset and to exploit the unique advantages of each of the models.
Author Contributions
AV-M, MG-G, LG-C, and HM-M conceived the literature revision, retrieved information from databases, analyzed information, drafted the manuscript, and approved the final version of it. All authors contributed to the article and approved the submitted version.
Funding
This work was supported by Consejo Nacional de Ciencia y Tecnología (ref. FC 2015-02-834 and Ciencia de Frontera 2019-6380) and Red Temática Glicociencia en Salud (CONACYT-México).
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Acosta Davila, J. A., and Hernandez De Los Rios, A. (2019). An overview of peripheral blood mononuclear cells as a model for immunological research of Toxoplasma gondii and other apicomplexan parasites. Front. Cell Infect. Microbiol. 9:24. doi: 10.3389/fcimb.2019.00024
Alegranci, P., de Abreu Ribeiro, L. C., Ferreira, L. S., Negrini Tde, C., Maia, D. C., Tansini, A., et al. (2013). The predominance of alternatively activated macrophages following challenge with cell wall peptide-polysaccharide after prior infection with Sporothrix schenckii. Mycopathologia 176, 57–65. doi: 10.1007/s11046-013-9663-y
Almeida-Paes, R., de Oliveira, L. C., Oliveira, M. M. E., Gutierrez-Galhardo, M. C., Nosanchuk, J. D., and Zancopé-Oliveira, R. M. (2015). Phenotypic characteristics associated with virulence of clinical isolates from the Sporothrix complex. Biomed. Res. Int. 2015, 212308–212308. doi: 10.1155/2015/212308
Almeida-Paes, R., Frases, S., Araújo, G. d. S., de Oliveira, M. M. E., Gerfen, G. J., Nosanchuk, J.D., et al. (2012). Biosynthesis and functions of a melanoid pigment produced by species of the Sporothrix complex in the presence of L-tyrosine. Appl. Environ. Microbiol. 78, 8623–8630. doi: 10.1128/AEM.02414-12
Arrillaga-Moncrieff, I., Capilla, J., Mayayo, E., Marimon, R., Mariné, M., Gené, J., et al. (2009). Different virulence levels of the species of Sporothrix in a murine model. Clin. Microbiol. Infect. 15, 651–655. doi: 10.1111/j.1469-0691.2009.02824.x
Barbee, W. C., Ewert, A., and Davidson, E. M. (1977). Animal model of human disease: sporotrichosis. Am. J. Pathol. 86, 281–284.
Barros, M. B. d. L., de Almeida Paes, R., and Schubach, A. O. (2011). Sporothrix schenckii and sporotrichosis. Clin. Microbiol. Rev. 24, 633–654. doi: 10.1128/CMR.00007-11
Batista-Duharte, A., Téllez-Martínez, D., Aparecida Jellmayer, J., Leandro Portuondo Fuentes, D., Campos Polesi, M., Martins Baviera, A., et al. (2018a). Repeated exposition to mercury (ii) chloride enhances susceptibility to S. schenckii sensu stricto infection in mice. J. Fungi 4:64. doi: 10.3390/jof4020064
Batista-Duharte, A., Téllez-Martínez, D., de Andrade, C. R., Polesi, M. C., Portuondo, D. L., and Carlos, I. Z. (2020). Transient Foxp3(+) regulatory T-cell depletion enhances protective Th1/Th17 immune response in murine sporotrichosis caused by Sporothrix schenckii. Immunobiology 225:151993. doi: 10.1016/j.imbio.2020.151993
Batista-Duharte, A., Téllez-Martínez, D., Roberto de Andrade, C., Portuondo, D. L., Jellmayer, J. A., Polesi, M. C., et al. (2018b). Sporothrix brasiliensis induces a more severe disease associated with sustained Th17 and regulatory T cells responses than Sporothrix schenckii sensu stricto in mice. Fungal Biol. 122, 1163–1170. doi: 10.1016/j.funbio.2018.08.004
Bergin, D., Murphy, L., Keenan, J., Clynes, M., and Kavanagh, K. (2006). Pre-exposure to yeast protects larvae of Galleria mellonella from a subsequent lethal infection by Candida albicans and is mediated by the increased expression of antimicrobial peptides. Microbes Infect. 8, 2105–2112. doi: 10.1016/j.micinf.2006.03.005
Binder, U., Maurer, E., and Lass-Flörl, C. (2016). Galleria mellonella: an invertebrate model to study pathogenicity in correctly defined fungal species. Fungal Biol. 120, 288–295. doi: 10.1016/j.funbio.2015.06.002
Borba-Santos, L. P., Barreto, T. L., Vila, T., Chi, K. D., Dos Santos Monti, F., de Farias, M. R., et al. (2021). In vitro and in vivo antifungal activity of buparvaquone against Sporothrix brasiliensis. Antimicrob. Agents Chemother. 65:e0069921. doi: 10.1128/AAC.00699-21
Borba-Santos, L. P., Vila, T., and Rozental, S. (2020). Identification of two potential inhibitors of Sporothrix brasiliensis and Sporothrix schenckii in the Pathogen Box collection. PLoS ONE 15:e0240658. doi: 10.1371/journal.pone.0240658
Brennan, M., Thomas, D. Y., Whiteway, M., and Kavanagh, K. (2002). Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae. FEMS Immunol. Med. Microbiol. 34, 153–157. doi: 10.1111/j.1574-695X.2002.tb00617.x
Brilhante, R. S. N., Fernandes, M. R., Pereira, V. S., Costa, A. D. C., Oliveira, J. S., de Aguiar, L., et al. (2021). Biofilm formation on cat claws by Sporothrix species: an ex vivo model. Microb. Pathogen. 150:104670. doi: 10.1016/j.micpath.2020.104670
Brito, M. M., Conceição-Silva, F., Morgado, F. N., Raibolt, P. S., Schubach, A., Schubach, T. P., et al. (2007). Comparison of virulence of different Sporothrix schenckii clinical isolates using experimental murine model. Med. Mycol. 45, 721–729. doi: 10.1080/13693780701625131
Cambi, A., Netea, M. G., Mora-Montes, H. M., Gow, N. A., Hato, S. V., Lowman, D. W., et al. (2008). Dendritic cell interaction with Candida albicans critically depends on N-linked mannan. J. Biol. Chem. 283, 20590–20599. doi: 10.1074/jbc.M709334200
Canteri de Souza, P., Custódio Caloni, C., Wilson, D., and Sergio Almeida, R. (2018). An invertebrate host to study fungal infections, mycotoxins and antifungal drugs: Tenebrio molitor. J. Fungi 4:125. doi: 10.3390/jof4040125
Carlos, I. Z., Sass,á, M. F., da Graça Sgarbi, D. B., Placeres, M. C., and Maia, D. C. (2009). Current research on the immune response to experimental sporotrichosis. Mycopathologia 168, 1–10. doi: 10.1007/s11046-009-9190-z
Carlos, I. Z., Sgarbi, D. B., Angluster, J., Alviano, C. S., and Silva, C. L. (1992). Detection of cellular immunity with the soluble antigen of the fungus Sporothrix schenckii in the systemic form of the disease. Mycopathologia 117, 139–144. doi: 10.1007/BF00442774
Castro, R. A., Kubitschek-Barreira, P. H., Teixeira, P. A., Sanches, G. F., Teixeira, M. M., Quintella, L. P., et al. (2013). Differences in cell morphometry, cell wall topography and gp70 expression correlate with the virulence of Sporothrix brasiliensis clinical isolates. PLoS ONE 8:e75656. doi: 10.1371/journal.pone.0075656
Castro, V. S., Da Silva, A. S., Costa, M. M., Paim, F. C., Alves, S. H., Lopes, S. T., et al. (2016). Cholinergic enzymes and inflammatory markers in rats infected by Sporothrix schenckii. Microb. Pathogen. 97, 94–102. doi: 10.1016/j.micpath.2016.05.020
Castro, V. S. P., Da Silva, A. S., Thomé, G. R., Wolkmer, P., Castro, J. L. C., Costa, M. M., et al. (2017). Oxidative stress in rats experimentally infected by Sporothrix schenckii. Microb. Pathogen. 107, 1–5. doi: 10.1016/j.micpath.2017.03.001
Chakrabarti, A., Bonifaz, A., Gutierrez-Galhardo, M. C., Mochizuki, T., and Li, S. (2015). Global epidemiology of sporotrichosis. Medical Mycol. 53, 3–14. doi: 10.1093/mmy/myu062
Chambers, J. A., and Thompson, J. E. (1976). Phagocytosis and pinocytosis in Acanthamoeba castellanii. J. Gen. Microbiol. 92, 246–250. doi: 10.1099/00221287-92-2-246
Chamilos, G., Lionakis, M. S., Lewis, R. E., and Kontoyiannis, D. P. (2007). Role of mini-host models in the study of medically important fungi. Lancet Infect. Dis. 7, 42–55. doi: 10.1016/S1473-3099(06)70686-7
Charoenvit, Y., and Taylor, R. L. (1979). Experimental sporotrichosis in Syrian hamsters. Infect. Immun. 23, 366–372. doi: 10.1128/iai.23.2.366-372.1979
Clavijo-Giraldo, D. M., Matinez-Alvarez, J. A., Lopes-Bezerra, L. M., Ponce-Noyola, P., Franco, B., Almeida, R. S., et al. (2016). Analysis of Sporothrix schenckii sensu stricto and Sporothrix brasiliensis virulence in Galleria mellonella. J. Microbiol. Methods 122, 73–77. doi: 10.1016/j.mimet.2016.01.014
Clemons, K. V., and Stevens, D. A. (2005). The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence. Med. Mycol. 43(Suppl.1), S101–110. doi: 10.1080/13693780500051919
Contreras-Garduño, J., Rodríguez, M. C., Hernández-Martínez, S., Martínez-Barnetche, J., Alvarado-Delgado, A., Izquierdo, J., et al. (2015). Plasmodium berghei induced priming in Anopheles albimanus independently of bacterial co-infection. Dev. Comp. Immunol. 52, 172–181. doi: 10.1016/j.dci.2015.05.004
Cruz Choappa, R., Pérez Gaete, S., Rodríguez Badilla, V., Vieille Oyarzo, P., and Opazo Sanchez, H. (2016). Virulence of Sporothrix globosa in murine models. Rev. Argent Microbiol. 48, 196–199. doi: 10.1016/j.ram.2016.04.007
de Almeida, J. R., Kaihami, G. H., Jannuzzi, G. P., and de Almeida, S. R. (2015). Therapeutic vaccine using a monoclonal antibody against a 70-kDa glycoprotein in mice infected with highly virulent Sporothrix schenckii and Sporothrix brasiliensis. Medical Mycol. 53, 42–50. doi: 10.1093/mmy/myu049
de Almeida, J. R. F., Jannuzzi, G. P., Kaihami, G. H., Breda, L. C. D., Ferreira, K. S., and de Almeida, S. R. (2018). An immunoproteomic approach revealing peptides from Sporothrix brasiliensis that induce a cellular immune response in subcutaneous sporotrichosis. Sci. Rep. 8:4192. doi: 10.1038/s41598-018-22709-8
de Almeida, J. R. F., Santiago, K. L., Kaihami, G. H., Maranhão, A. Q., de Macedo Brígido, M., and de Almeida, S. R. (2017). The efficacy of humanized antibody against the Sporothrix antigen, gp70, in promoting phagocytosis and reducing disease burden. Front. Microbiol. 8, 345–345. doi: 10.3389/fmicb.2017.00345
de Beer, Z. W., Duong, T. A., and Wingfield, M. J. (2016). The divorce of Sporothrix and Ophiostoma: solution to a problematic relationship. Stud. Mycol. 83, 165–191. doi: 10.1016/j.simyco.2016.07.001
de Capriles, C. C., Mata Essayag, S., Lander, A., and Camacho, R. (1993). Experimental pathogenicity of Sporothrix schenckii preserved in water (Castellani). Mycopathologia 122, 129–133. doi: 10.1007/BF01103472
de Souza, P. C., Morey, A. T., Castanheira, G. M., Bocate, K. P., Panagio, L. A., Ito, F. A., et al. (2015). Tenebrio molitor (Coleoptera: Tenebrionidae) as an alternative host to study fungal infections. J. Microbiol. Methods 118, 182–186. doi: 10.1016/j.mimet.2015.10.004
Della Terra, P. P., Rodrigues, A. M., Fernandes, G. F., Nishikaku, A. S., Burger, E., and de Camargo, Z. P. (2017). Exploring virulence and immunogenicity in the emerging pathogen Sporothrix brasiliensis. PLoS Negl. Trop. Dis. 11:e0005903. doi: 10.1371/journal.pntd.0005903
Dickerson, C. L., Taylor, R. L., and Drutz, D. J. (1983). Susceptibility of congenitally athymic (nude) mice to sporotrichosis. Infect. Immun. 40, 417–420. doi: 10.1128/iai.40.1.417-420.1983
Dixon, D. M., Duncan, R. A., and Hurd, N. J. (1992). Use of a mouse model to evaluate clinical and environmental isolates of Sporothrix spp. from the largest U.S. epidemic of sporotrichosis. J. Clin. Microbiol. 30, 951–954. doi: 10.1128/jcm.30.4.951-954.1992
Dixon, D. M., Salkin, I. F., Duncan, R. A., Hurd, N. J., Haines, J. H., Kemna, M. E., et al. (1991). Isolation and characterization of Sporothrix schenckii from clinical and environmental sources associated with the largest U.S. epidemic of sporotrichosis. J. Clin. Microbiol. 29, 1106–1113. doi: 10.1128/jcm.29.6.1106-1113.1991
Etchecopaz, A. N., Lanza, N., Toscanini, M. A., Devoto, T. B., Pola, S. J., Daneri, G. L., et al. (2020). Sporotrichosis caused by Sporothrix brasiliensis in Argentina: case report, molecular identification and in vitro susceptibility pattern to antifungal drugs. J. Mycol. Med. 30:100908. doi: 10.1016/j.mycmed.2019.100908
Fernandes, G. F., dos Santos, P. O., Rodrigues, A. M., Sasaki, A. A., Burger, E., and de Camargo, Z. P. (2013). Characterization of virulence profile, protein secretion and immunogenicity of different Sporothrix schenckii sensu stricto isolates compared with S. globosa and S. brasiliensis species. Virulence 4, 241–249. doi: 10.4161/viru.23112
Fernandes, K. S. S., Mathews, H. L., and Bezerra, L. M. L. (1999). Differences in virulence of Sporothrix schenckii conidia related to culture conditions and cell-wall components. J. Med. Microbiol. 48, 195–203. doi: 10.1099/00222615-48-2-195
Fernández-Silva, F., Capilla, J., Mayayo, E., and Guarro, J. (2012a). Efficacy of posaconazole in murine experimental sporotrichosis. Antimicrobial. Agent. Chemother. 56, 2273–2277. doi: 10.1128/AAC.05376-11
Fernández-Silva, F., Capilla, J., Mayayo, E., and Guarro, J. (2012b). Virulence of Sporothrix luriei in a murine model of disseminated infection. Mycopathologia 173, 245–249. doi: 10.1007/s11046-011-9506-7
Figueiredo, C. C., De Lima, O. C., De Carvalho, L., Lopes-Bezerra, L. M., and Morandi, V. (2004). The in vitro interaction of Sporothrix schenckii with human endothelial cells is modulated by cytokines and involves endothelial surface molecules. Microb. Pathogen. 36, 177–188. doi: 10.1016/j.micpath.2003.11.003
Filler, S. G., and Sheppard, D. C. (2006). Fungal invasion of normally non-phagocytic host cells. PLoS Pathog. 2:e129. doi: 10.1371/journal.ppat.0020129
Fornari, G., Gomes, R. R., Degenhardt-Goldbach, J., Dos Santos, S. S., de Almeida, S. R., Dos Santos, G. D., et al. (2018). A model for trans-kingdom pathogenicity in Fonsecaea agents of human chromoblastomycosis. Front. Microbiol. 9, 2211–2211. doi: 10.3389/fmicb.2018.02211
Garcia-Carnero, L. C., Clavijo-Giraldo, D. M., Gomez-Gaviria, M., Lozoya-Perez, N. E., Tamez-Castrellon, A. K., Lopez-Ramirez, L. A., et al. (2020). Early virulence predictors during the Candida species-Galleria mellonella interaction. J. Fungi. 6:30152. doi: 10.3390/jof6030152
García-Carnero, L. C., Salinas-Marín, R., Lozoya-Pérez, N. E., Wrobel, K., Wrobel, K., Martínez-Duncker, I., et al. (2021). The heat shock protein 60 and pap1 participate in the Sporothrix schenckii-host interaction. J. Fungi. 7:960. doi: 10.3390/jof7110960
Gomes, M. C., and Mostowy, S. (2020). The case for modeling human infection in zebrafish. Trends Microbiol. 28, 10–18. doi: 10.1016/j.tim.2019.08.005
Gonzalez-Hernandez, R. J., Jin, K., Hernandez-Chavez, M. J., Diaz-Jimenez, D. F., Trujillo-Esquivel, E., Clavijo-Giraldo, D. M., et al. (2017). Phosphomannosylation and the functional analysis of the extended Candida albicans MNN4-like gene family. Front. Microbiol. 8:2156. doi: 10.3389/fmicb.2017.02156
Gremião, I. D., Miranda, L. H., Reis, E. G., Rodrigues, A. M., and Pereira, S. A. (2017). Zoonotic epidemic of sporotrichosis: cat to human transmission. PLoS Pathog. 13:e1006077. doi: 10.1371/journal.ppat.1006077
Guzman Beltrán, S., Sanchez Morales, J., González Canto, A., Escalona Montaño, A., and Torres Guerrero, H. (2021). Human serum proteins bind to Sporothrix schenckii conidia with differential effects on phagocytosis. Brazil. J. Microbiol. 52, 33–39. doi: 10.1007/s42770-020-00276-3
Guzman-Beltran, S., Perez-Torres, A., Coronel-Cruz, C., and Torres-Guerrero, H. (2012). Phagocytic receptors on macrophages distinguish between different Sporothrix schenckii morphotypes. Microb. Infect. 14, 1093–1101. doi: 10.1016/j.micinf.2012.06.001
Hernandez-Chavez, M. J., Clavijo-Giraldo, D. M., Novak, A., Lozoya-Perez, N. E., Martinez-Alvarez, J. A., Salinas-Marin, R., et al. (2019). Role of protein mannosylation in the Candida tropicalis-host Interaction. Front. Microbiol. 10:2743. doi: 10.3389/fmicb.2019.02743
Hernandez-Chavez, M. J., Franco, B., Clavijo-Giraldo, D. M., Hernandez, N. V., Estrada-Mata, E., and Mora-Montes, H. M. (2018). Role of protein phosphomannosylation in the Candida tropicalis-macrophage interaction. FEMS Yeast Res. 18:foy053. doi: 10.1093/femsyr/foy053
Hohl, T. M. (2014). Overview of vertebrate animal models of fungal infection. J. Immunol. Methods 410, 100–112. doi: 10.1016/j.jim.2014.03.022
Huang, L., Zhang, J., Du, W., Liang, Z., Li, M., Wu, R., et al. (2021). Chitin-rich heteroglycan from Sporothrix schenckii sensu stricto potentiates fungal clearance in a mouse model of sporotrichosis and promotes macrophages phagocytosis. BMC Microbiol. 21:190. doi: 10.1186/s12866-021-02243-w
Ikeda, M. A. K., de Almeida, J. R. F., Jannuzzi, G. P., Cronemberger-Andrade, A., Torrecilhas, A. C. T., Moretti, N. S., et al. (2018). Extracellular vesicles from Sporothrix brasiliensis are an important virulence factor that induce an increase in fungal burden in experimental sporotrichosis. Front. Microbiol. 9, 2286–2286. doi: 10.3389/fmicb.2018.02286
Jacobsen, I. D. (2014). Galleria mellonella as a model host to study virulence of Candida. Virulence 5, 237–239. doi: 10.4161/viru.27434
Jellmayer, J. A., Ferreira, L. S., Manente, F. A., Gonçalves, A. C., Polesi, M. C., Batista-Duharte, A., et al. (2017). Dectin-1 expression by macrophages and related antifungal mechanisms in a murine model of Sporothrix schenckii sensu stricto systemic infection. Microbial Pathogen. 110, 78–84. doi: 10.1016/j.micpath.2017.06.025
Jiao, Q., Luo, Y., Scheffel, J., Geng, P., Wang, Y., Frischbutter, S., et al. (2020). Skin mast cells contribute to Sporothrix schenckii infection. Front. Immunol. 11, 469–469. doi: 10.3389/fimmu.2020.00469
Kajiwara, H., Saito, M., Ohga, S., Uenotsuchi, T., and Yoshida, S.-,i. (2004). Impaired host defense against Sporothrix schenckii in mice with chronic granulomatous disease. Infect. Immun. 72, 5073–5079. doi: 10.1128/IAI.72.9.5073-5079.2004
Kan, V. L., and Bennett, J. E. (1988). Efficacies of four antifungal agents in experimental murine sporotrichosis. Antimicrob. Agents Chemother. 32, 1619–1623. doi: 10.1128/AAC.32.11.1619
Kavanagh, K., and Reeves, E. P. (2004). Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens. FEMS Microbiol. Rev. 28, 101–112. doi: 10.1016/j.femsre.2003.09.002
Kavanagh, K., and Sheehan, G. (2018). The use of Galleria mellonella larvae to identify novel antimicrobial agents against fungal species of medical interest. J. Fungi 4:jof4030113. doi: 10.3390/jof4030113
Klotz, S. A. (1992). Fungal adherence to the vascular compartment: a critical step in the pathogenesis of disseminated candidiasis. Clin. Infect. Dis. 14, 340–347. doi: 10.1093/clinids/14.1.340
Kogan, T. V., Jadoun, J., Mittelman, L., Hirschberg, K., and Osherov, N. (2004). Involvement of secreted Aspergillus fumigatus proteases in disruption of the actin fiber cytoskeleton and loss of focal adhesion sites in infected A549 lung pneumocytes. J. Infect. Dis. 189, 1965–1973. doi: 10.1086/420850
Kong, X., Xiao, T., Lin, J., Wang, Y., and Chen, H. D. (2006). Relationships among genotypes, virulence and clinical forms of Sporothrix schenckii infection. Clin. Microbiol. Infect. 12, 1077–1081. doi: 10.1111/j.1469-0691.2006.01519.x
Kühbacher, A., Sohn, K., Burger-Kentischer, A., and Rupp, S. (2017). Immune cell-supplemented human skin model for studying fungal infections. Methods Mol. Biol. 1508, 439–449. doi: 10.1007/978-1-4939-6515-1_25
Kwon-Chung, K. J. (1979). Comparison of isolates of Sporothrix schenckii obtained from fixed cutaneous lesions with isolates from other types of lesions. J. Infect. Dis. 139, 424–431. doi: 10.1093/infdis/139.4.424
Last, A., Maurer, M., and Hube, B. (2021). In vitro infection models to study fungal-host interactions. FEMS Microbiol. Rev. 45:fuab005. doi: 10.1093/femsre/fuab005
Lima, O. C., Figueiredo, C. C., Pereira, B. A., Coelho, M. G., Morandi, V., and Lopes-Bezerra, L. M. (1999). Adhesion of the human pathogen Sporothrix schenckii to several extracellular matrix proteins. Braz. J. Med. Biol. Res. 32, 651–657. doi: 10.1590/S0100-879X1999000500020
Limmer, S., Quintin, J., Hetru, C., and Ferrandon, D. (2011). Virulence on the fly: Drosophila melanogaster as a model genetic organism to decipher host-pathogen interactions. Curr. Drug Target. 12, 978–999. doi: 10.2174/138945011795677818
Lopes Alves, L., Travassos, L. R., Previato, J. O., and Mendonça-Previato, L. (1994). Novel antigenic determinants from peptidorhamnomannans of Sporothrix schenckii. Glycobiology 4, 281–288. doi: 10.1093/glycob/4.3.281
Lopes-Bezerra, L. M. (2011). Sporothrix schenckii cell wall peptidorhamnomannans. Front. Microbiol. 2:243. doi: 10.3389/fmicb.2011.00243
Lopes-Bezerra, L. M., Mora-Montes, H. M., Zhang, Y., Nino-Vega, G., Rodrigues, A. M., de Camargo, Z. P., et al. (2018a). Sporotrichosis between 1898 and 2017: the evolution of knowledge on a changeable disease and on emerging etiological agents. Med. Mycol. 56, 126–143. doi: 10.1093/mmy/myx103
Lopes-Bezerra, L. M., Walker, L. A., Nino-Vega, G., Mora-Montes, H. M., Neves, G. W. P., Villalobos-Duno, H., et al. (2018b). Cell walls of the dimorphic fungal pathogens Sporothrix schenckii and Sporothrix brasiliensis exhibit bilaminate structures and sloughing of extensive and intact layers. PLoS Negl. Trop. Dis. 12:e0006169. doi: 10.1371/journal.pntd.0006169
López-Romero, E., Reyes-Montes Mdel, R., Pérez-Torres, A., Ruiz-Baca, E., Villagómez-Castro, J. C., Mora-Montes, H. M., et al. (2011). Sporothrix schenckii complex and sporotrichosis, an emerging health problem. Fut. Microbiol. 6, 85–102. doi: 10.2217/fmb.10.157
Lossi, L., and Merighi, A. (2018). The use of ex vivo rodent platforms in neuroscience translational research with attention to the 3Rs philosophy. Front. Vet. Sci. 5, 164–164. doi: 10.3389/fvets.2018.00164
Lozoya-Perez, N. E., Casas-Flores, S., de Almeida, J. R. F., Martinez-Alvarez, J. A., Lopez-Ramirez, L. A., Jannuzzi, G. P., et al. (2019). Silencing of OCH1 unveils the role of Sporothrix schenckii N-linked glycans during the host-fungus interaction. Infect. Drug Resist. 12, 67–85. doi: 10.2147/IDR.S185037
Lozoya-Perez, N. E., Casas-Flores, S., Martinez-Alvarez, J. A., Lopez-Ramirez, L. A., Lopes-Bezerra, L. M., Franco, B., et al. (2018). Generation of Sporothrix schenckii mutants expressing the green fluorescent protein suitable for the study of host-fungus interactions. Fungal Biol. 122, 1023–1030. doi: 10.1016/j.funbio.2018.07.004
Lozoya-Pérez, N. E., Clavijo-Giraldo, D. M., Martínez-Duncker, I., García-Carnero, L. C., López-Ramírez, L. A., Niño-Vega, G. A., et al. (2020). Influences of the culturing media in the virulence and cell wall of Sporothrix schenckii, Sporothrix brasiliensis, and Sporothrix globosa. J. Fungi 6:323. doi: 10.3390/jof6040323
Lozoya-Perez, N. E., Garcia-Carnero, L. C., Martinez-Alvarez, J. A., Martinez-Duncker, I., and Mora-Montes, H. M. (2021). Tenebrio molitor as an alternative model to analyze the Sporothrix species virulence. Infect. Drug Resist. 14, 2059–2072. doi: 10.2147/IDR.S312553
MacArthur Clark, J. (2018). The 3Rs in research: a contemporary approach to replacement, reduction and refinement. Br. J. Nutr. 120, S1–S7. doi: 10.1017/S0007114517002227
Macêdo-Sales, P. A., Souto, S. R. L. S., Destefani, C. A., Lucena, R. P., Machado, R. L. D., Pinto, M. R., et al. (2018). Domestic feline contribution in the transmission of Sporothrix in Rio de Janeiro State, Brazil: a comparison between infected and non-infected populations. BMC Vet. Res. 14:19. doi: 10.1186/s12917-018-1340-4
Maciel Quatrin, P., Flores Dalla Lana, D., Andrzejewski Kaminski, T. F., and Meneghello Fuentefria, A. (2019). Fungal infection models: current progress of ex vivo methods. Mycoses 62, 860–873. doi: 10.1111/myc.12961
Malavia, D., Gow, N. A. R., and Usher, J. (2020). Advances in molecular tools and in vivo models for the study of human fungal pathogenesis. Microorganisms 8:803. doi: 10.3390/microorganisms8060803
Manente, F. A., Quinello, C., Ferreira, L. S., de Andrade, C. R., Jellmayer, J. A., Portuondo, D. L., et al. (2018). Experimental sporotrichosis in a cyclophosphamide-induced immunosuppressed mice model. Med. Mycol. 56, 711–722. doi: 10.1093/mmy/myx098
Mario, D. N., Guarro, J., Santurio, J. M., Alves, S. H., and Capilla, J. (2015). In vitro and in vivo efficacy of amphotericin B combined with posaconazole against experimental disseminated sporotrichosis. Antimicrob. Agents Chemother. 59, 5018–5021. doi: 10.1128/AAC.00052-15
Martinez-Alvarez, J. A., Garcia-Carnero, L. C., Kubitschek-Barreira, P. H., Lozoya-Perez, N. E., Belmonte-Vazquez, J. L., de Almeida, J. R., et al. (2019). Analysis of some immunogenic properties of the recombinant Sporothrix schenckii Gp70 expressed in Escherichia coli. Fut. Microbiol. 14, 397–410. doi: 10.2217/fmb-2018-0295
Martinez-Alvarez, J. A., Perez-Garcia, L. A., Flores-Carreon, A., and Mora-Montes, H. M. (2014). The immune response against Candida spp. and Sporothrix schenckii. Revista Iberoamericana de Micologia 31, 62–66. doi: 10.1016/j.riam.2013.09.015
Martinez-Alvarez, J. A., Perez-Garcia, L. A., Mellado-Mojica, E., Lopez, M. G., Martinez-Duncker, I., Lopes-Bezerra, L. M., et al. (2017). Sporothrix schenckii sensu stricto and Sporothrix brasiliensis are differentially recognized by human peripheral blood mononuclear cells. Front. Microbiol. 8:843. doi: 10.3389/fmicb.2017.00843
McKenzie, C. G., Koser, U., Lewis, L. E., Bain, J. M., Mora-Montes, H. M., Barker, R. N., et al. (2010). Contribution of Candida albicans cell wall components to recognition by and escape from murine macrophages. Infect. Immun. 78, 1650–1658. doi: 10.1128/IAI.00001-10
Meinerz, A. R., Xavier, M. O., Cleff, M. B., Madrid, I. M., Nobre, M. O., Meireles, M. C., et al. (2008). Efficacy of terbinafine and itraconazole on a experimental model of systemic sporotrichosis. Brazil. J. Microbiol. 39, 734–737. doi: 10.1590/S1517-83822008000400025
Mora-Montes, H. M., Dantas Ada, S., Trujillo-Esquivel, E., de Souza Baptista, A. R., and Lopes-Bezerra, L. M. (2015). Current progress in the biology of members of the Sporothrix schenckii complex following the genomic era. FEMS Yeast Res. 15:fov065. doi: 10.1093/femsyr/fov065
Murphy, J. W., Gregory, J. A., and Larsh, H. W. (1974). Skin testing of guinea pigs and footpad testing of mice with a new antigen for detecting delayed hypersensitivity to Cryptococcus neoformans. Infect. Immun. 9, 404–409. doi: 10.1128/iai.9.2.404-409.1974
Mylonakis, E. (2008). Galleria mellonella and the study of fungal pathogenesis: making the case for another genetically tractable model host. Mycopathologia 165, 1–3. doi: 10.1007/s11046-007-9082-z
Nascimento, R. C., and Almeida, S. R. (2005). Humoral immune response against soluble and fractionate antigens in experimental sporotrichosis. FEMS Immunol. Med. Microbiol. 43, 241–247. doi: 10.1016/j.femsim.2004.08.004
Nascimento, R. C., Espíndola, N. M., Castro, R. A., Teixeira, P. A., Loureiro y Penha, C. V., Lopes-Bezerra, L. M., et al. (2008). Passive immunization with monoclonal antibody against a 70-kDa putative adhesin of Sporothrix schenckii induces protection in murine sporotrichosis. Eur. J. Immunol. 38, 3080–3089. doi: 10.1002/eji.200838513
Navarro-Arias, M. J., Defosse, T. A., Dementhon, K., Csonka, K., Mellado-Mojica, E., Dias Valerio, A., et al. (2016). Disruption of protein mannosylation affects Candida guilliermondii cell wall, immune sensing, and virulence. Front. Microbiol. 7:1951. doi: 10.3389/fmicb.2016.01951
Negrini Tde, C., Ferreira, L. S., Alegranci, P., Arthur, R. A., Sundfeld, P. P., Maia, D. C., et al. (2013). Role of TLR-2 and fungal surface antigens on innate immune response against Sporothrix schenckii. Immunol. Investig. 42, 36–48. doi: 10.3109/08820139.2012.719982
Netea, M. G., Brown, G. D., Kullberg, B. J., and Gow, N. A. (2008). An integrated model of the recognition of Candida albicans by the innate immune system. Nat. Rev. Microbiol. 6, 67–78. doi: 10.1038/nrmicro1815
Neves, G. W. P., Wong, S. S. W., Aimanianda, V., Simenel, C., Guijarro, J. I., Walls, C., et al. (2021). Complement-mediated differential immune response of human macrophages to Sporothrix species through interaction with their cell wall peptidorhamnomannans. Front. Immunol. 12:749074. doi: 10.3389/fimmu.2021.749074
Odds, F. C., Van Nuffel, L., and Gow, N. A. R. (2000). Survival in experimental Candida albicans infections depends on inoculum growth conditions as well as animal host. Microbiology 146, 1881–1889. doi: 10.1099/00221287-146-8-1881
Ohnemus, U., Willers, C., Bubenheim, M., Horstkotte, M. A., Houdek, P., Fischer, F., et al. (2008). An ex-vivo oral mucosa infection model for the evaluation of the topical activity of antifungal agents. Mycoses 51, 21–29. doi: 10.1111/j.1439-0507.2007.01445.x
Orofino-Costa, R., Macedo, P. M., Rodrigues, A. M., and Bernardes-Engemann, A. R. (2017). Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics. Anais Brasileiros de Dermatologia 92, 606–620. doi: 10.1590/abd1806-4841.2017279
Passos, J. S., Martino, L. C., Dartora, V. F. C., Araujo, G. L. B., Ishida, K., and Lopes, L. B. (2020). Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole. Eur. J. Pharmaceut. Sci. 149:105296. doi: 10.1016/j.ejps.2020.105296
Pereira, S. A., Passos, S. R., Silva, J. N., Gremião, I. D., Figueiredo, F. B., Teixeira, J. L., et al. (2010). Response to azolic antifungal agents for treating feline sporotrichosis. Vet. Record 166, 290–294. doi: 10.1136/vr.166.10.290
Pereira, T. C., de Barros, P. P., Fugisaki, L. R. O., Rossoni, R. D., Ribeiro, F. C., de Menezes, R. T., et al. (2018). Recent advances in the use of Galleria mellonella model to study immune responses against human pathogens. J. Fungi 4:40128. doi: 10.3390/jof4040128
Perez-Garcia, L. A., Csonka, K., Flores-Carreon, A., Estrada-Mata, E., Mellado-Mojica, E., Nemeth, T., et al. (2016). Role of protein glycosylation in Candida parapsilosis cell wall integrity and host interaction. Front. Microbiol. 7:306. doi: 10.3389/fmicb.2016.00306
Pohanka, M. (2013). Role of oxidative stress in infectious diseases. A review. Folia Microbiol. 58, 503–513. doi: 10.1007/s12223-013-0239-5
Rodrigues, A. M., de Hoog, G. S., and de Camargo, Z. P. (2016). Sporothrix species causing outbreaks in animals and humans driven by animal-animal transmission. PLoS Pathog. 12:e1005638. doi: 10.1371/journal.ppat.1005638
Romo-Lozano, Y., Hernández-Hernández, F., and Salinas, E. (2012). Mast cell activation by conidia of Sporothrix schenckii: role in the severity of infection. Scand. J. Immunol. 76, 11–20. doi: 10.1111/j.1365-3083.2012.02706.x
Romo-Lozano, Y., Hernández-Hernández, F., and Salinas, E. (2014). Sporothrix schenckii yeasts induce ERK pathway activation and secretion of IL-6 and TNF-α in rat mast cells, but no degranulation. Med. Mycol. 52, 862–868. doi: 10.1093/mmy/myu055
Rosowski, E. E., Knox, B. P., Archambault, L. S., Huttenlocher, A., Keller, N. P., Wheeler, R. T., et al. (2018). The zebrafish as a model host for invasive fungal infections. J. Fungi 4:136. doi: 10.3390/jof4040136
Rossato, L., Santos, S. S. D., Ferreira, L. G., and de Almeida, S. R. (2019). The importance of Toll-like receptor 4 during experimental Sporothrix brasiliensis infection. Med. Mycol. 57, 489–495. doi: 10.1093/mmy/myy048
Ruiz-Baca, E., Toriello, C., Perez-Torres, A., Sabanero-Lopez, M., Villagomez-Castro, J. C., and Lopez-Romero, E. (2009). Isolation and some properties of a glycoprotein of 70 kDa (Gp70) from the cell wall of Sporothrix schenckii involved in fungal adherence to dermal extracellular matrix. Med. Mycol. 47, 185–196. doi: 10.1080/13693780802165789
Sabanero López, M., Flores Villavicencio, L. L., Soto Arredondo, K., Barbosa Sabanero, G., Villagómez-Castro, J. C., Cruz Jiménez, G., et al. (2018). Proteases of Sporothrix schenckii: cytopathological effects on a host-cell model. Revista Iberoamericana de Micologia 35, 32–38. doi: 10.1016/j.riam.2017.05.003
Saluja, R., Metz, M., and Maurer, M. (2012). Role and relevance of mast cells in fungal infections. Front. Immunol. 3:146. doi: 10.3389/fimmu.2012.00146
Sandig, H., and Bulfone-Paus, S. (2012). TLR signaling in mast cells: common and unique features. Front. Immunol. 3:185. doi: 10.3389/fimmu.2012.00185
Sassá, M. F., Saturi, A. E. T., Souza, L. F., Ribeiro, L. C. d. A., Sgarbi, D. B. d. G., and Carlos, I. Z. (2009). Response of macrophage Toll-like receptor 4 to a Sporothrix schenckii lipid extract during experimental sporotrichosis. Immunology 128, 301–309. doi: 10.1111/j.1365-2567.2009.03118.x
Schindler, B., and Segal, E. (2008). Candida albicans metabolite affects the cytoskeleton and phagocytic activity of murine macrophages. Med. Mycol. 46, 251–258. doi: 10.1080/13693780701837157
Schubach, T. M., Schubach, A., Okamoto, T., Barros, M. B., Figueiredo, F. B., Cuzzi, T., et al. (2004). Evaluation of an epidemic of sporotrichosis in cats: 347 cases (1998–2001). J. Am. Vet. Med. Assoc. 224, 1623–1629. doi: 10.2460/javma.2004.224.1623
Shiraishi, A., Nakagaki, K., and Arai, T. (1992). Role of cell-mediated immunity in the resistance to experimental sporotrichosis in mice. Mycopathologia 120, 15–21. doi: 10.1007/BF00578497
Singulani, J. L., Scorzoni, L., de Oliveira, H. C., Marcos, C. M., Assato, P. A., Fusco-Almeida, A. M., et al. (2018). Applications of invertebrate animal models to dimorphic fungal infections. J. Fungi 4:118. doi: 10.3390/jof4040118
Sohnle, P. G., and Kirkpatrick, C. H. (1977). Study of possible mechanisms of basophil accumulation in experimental cutaneous candidiasis in guinea pigs. J. Allergy Clin. Immunol. 59, 171–177. doi: 10.1016/0091-6749(77)90221-4
Song, Y., Yao, L., Zhen, Y., Cui, Y., Zhong, S., Liu, Y., et al. (2021). Sporothrix globosa melanin inhibits antigen presentation by macrophages and enhances deep organ dissemination. Brazil. J. Microbiol. 52, 19–31. doi: 10.1007/s42770-020-00345-7
Steenbergen, J. N., Nosanchuk, J. D., Malliaris, S. D., and Casadevall, A. (2004). Interaction of Blastomyces dermatitidis, Sporothrix schenckii, and Histoplasma capsulatum with Acanthamoeba castellanii. Infect. Immun. 72, 3478–3488. doi: 10.1128/IAI.72.6.3478-3488.2004
Tabatabaei, F., Moharamzadeh, K., and Tayebi, L. (2020). Three-dimensional in vitro oral mucosa models of fungal and bacterial infections. Tissue Eng. B Rev. 26, 443–460. doi: 10.1089/ten.teb.2020.0016
Tachibana, T., Matsuyama, T., and Mitsuyama, M. (1998). Characteristic infectivity of Sporothrix schenckii to mice depending on routes of infection and inherent fungal pathogenicity. Med. Mycol. 36, 21–27. doi: 10.1080/02681219880000041
Tachibana, T., Matsuyama, T., and Mitsuyama, M. (1999). Involvement of CD4+ T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice. Med. Mycol. 37, 397–404. doi: 10.1046/j.1365-280X.1999.00239.x
Tamez-Castrellón, A. K., van der Beek, S. L., López-Ramírez, L. A., Martínez-Duncker, I., Lozoya-Pérez, N. E., van Sorge, N. M., et al. (2021). Disruption of protein rhamnosylation affects the Sporothrix schenckii-host interaction. Cell Surf. 7:100058. doi: 10.1016/j.tcsw.2021.100058
Taylor, P. R., Tsoni, S. V., Willment, J. A., Dennehy, K. M., Rosas, M., Findon, H., et al. (2007). Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat. Immunol. 8, 31–38. doi: 10.1038/ni1408
Teixeira, P. A., De Castro, R. A., Ferreira, F. R., Cunha, M. M., Torres, A. P., Penha, C. V., et al. (2010). L-DOPA accessibility in culture medium increases melanin expression and virulence of Sporothrix schenckii yeast cells. Med. Mycol. 48, 687–695. doi: 10.3109/13693780903453287
Teixeira, P. A., de Castro, R. A., Nascimento, R. C., Tronchin, G., Torres, A. P., Lazera, M., et al. (2009). Cell surface expression of adhesins for fibronectin correlates with virulence in Sporothrix schenckii. Microbiology 155, 3730–3738. doi: 10.1099/mic.0.029439-0
Tsubura, E., and Schwarz, J. (1961). Treatment of experimental sporotrichosis in mice. Mycopathol. Mycologia Applicata 14, 55–56. doi: 10.1007/BF02051437
Van Cutsem, J., Van Gerven, F., and Janssen, P. A. (1987). Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models. Rev. Infect. Dis. 9(Suppl.1), S15–S32. doi: 10.1093/clinids/9.Supplement_1.S15
Verdan, F. F., Faleiros, J. C., Ferreira, L. S., Monnazzi, L. G., Maia, D. C., Tansine, A., et al. (2012). Dendritic cell are able to differentially recognize Sporothrix schenckii antigens and promote Th1/Th17 response in vitro. Immunobiology 217, 788–794. doi: 10.1016/j.imbio.2012.04.006
Vigneron, A., Jehan, C., Rigaud, T., and Moret, Y. (2019). Immune defenses of a beneficial pest: the mealworm beetle, Tenebrio molitor. Front. Physiol. 10, 138–138. doi: 10.3389/fphys.2019.00138
Villalobos-Duno, H. L., Barreto, L. A., Alvarez-Aular, A., Mora-Montes, H. M., Lozoya-Perez, N. E., Franco, B., et al. (2021). Comparison of cell wall polysaccharide composition and structure between strains of Sporothrix schenckii and Sporothrix brasiliensis. Front. Microbiol. 12:726958. doi: 10.3389/fmicb.2021.726958
Keywords: pathogen-host interaction, virulence factors, animal model, antifungal drugs, immune response, invertebrate model, ex vivo model
Citation: Vargas-Macías AP, Gómez-Gaviria M, García-Carnero LC and Mora-Montes HM (2022) Current Models to Study the Sporothrix-Host Interaction. Front. Fungal Biol. 3:833111. doi: 10.3389/ffunb.2022.833111
Received: 10 December 2021; Accepted: 31 January 2022;
Published: 25 February 2022.
Edited by:
Teresa Zelante, University of Perugia, ItalyReviewed by:
Vishukumar Aimanianda, Institut Pasteur, FranceRosana Puccia, Federal University of São Paulo, Brazil
Copyright © 2022 Vargas-Macías, Gómez-Gaviria, García-Carnero and Mora-Montes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Héctor M. Mora-Montes, aG1vcmEmI3gwMDA0MDt1Z3RvLm14